RhIL-11 (Oprelvekin)– A Drug To Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11

Introduction:

As a leading manufacturer in China, we are proud to offer our high-quality product, RhIL-11 (Oprelvekin) – A Drug to Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11. This groundbreaking medication has been developed specifically to benefit patients who require an increase in their platelet count.

Our product has been carefully manufactured, undergoing rigorous testing and quality control measures to ensure that it meets the highest standards for safety and efficacy. Our RhIL-11 (Oprelvekin) is FDA-approved and has been trusted by medical professionals worldwide to provide safe and effective treatment to patients with platelet deficiencies.

What is RhIL-11 (Oprelvekin)?

RhIL-11 (Oprelvekin), also known as recombinant human interleukin-11, is a groundbreaking medication designed to stimulate the production of platelets in patients with low levels. It is a type of cytokine, which are naturally occurring proteins that regulate the immune system.

This medication works by targeting and stimulating the bone marrow, which is the site of platelet production. It helps to increase the number of platelets circulating in the patient's bloodstream, which can help to reduce their risk of bleeding and other complications associated with low platelet counts.

RhIL-11 (Oprelvekin) is an excellent choice for patients who are undergoing chemotherapy or other medical treatments, which can cause a decrease in platelet count. It can also be used for patients with various blood disorders, such as thrombocytopenia, myelodysplastic syndrome, and aplastic anemia.

The Benefits of RhIL-11 (Oprelvekin)

The benefits of using RhIL-11 (Oprelvekin) are numerous. For patients with low platelet counts, this medication can provide a significant improvement in their health and overall quality of life. Some of the benefits of using RhIL-11 (Oprelvekin) include:

1. Increased Platelet Count: By stimulating the bone marrow, RhIL-11 (Oprelvekin) can help to increase the number of platelets in the patient's bloodstream. This can help to reduce the risk of bleeding and other complications associated with low platelet counts.

2. Improved Quality of Life: Patients with low platelet counts often experience a variety of symptoms, such as fatigue, weakness, and bruising. By increasing the number of platelets in the patient's bloodstream, RhIL-11 (Oprelvekin) can help to reduce these symptoms and improve their overall quality of life.

3. Safe and Effective: RhIL-11 (Oprelvekin) has been extensively tested and has been found to be safe and effective for patients with low platelet counts. Its efficacy is well-documented, and it has been used safely by medical professionals worldwide.

4. FDA-Approved: Our RhIL-11 (Oprelvekin) is FDA-approved, providing peace of mind to medical professionals and patients alike that it has undergone rigorous testing and quality control measures to ensure its safety and efficacy.

Conclusion:

Overall, our RhIL-11 (Oprelvekin) – A Drug to Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11 is an excellent choice for medical professionals worldwide who are looking for a safe and effective treatment for their patients with low platelet counts. Its benefits are numerous, and it has been trusted by medical professionals worldwide for years to provide safe and effective treatment to patients with platelet deficiencies.

As a leading manufacturer in China, we are proud to offer our high-quality RhIL-11 (Oprelvekin) to merchants worldwide. We are committed to providing the highest quality products and services to our customers, and we are always available to answer any questions or provide additional information about our products.

[Name]

Generic Name: Oprelvekin

Chemical Name: Human Interleukin-11 for Injection

The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced thrombocytopenia.

[Indication]

Prevention and treatment of Chemoradiotherapy-induced thrombocytopenia.

Hangzhou Jiuyuan is a top-biotech joint venture specializing in the research, development, manufacture, and marketing of pharmaceuticals based on gene engineering and biochemical technology since 1993. It has gene engineering workshops, injection workshops, pharmaceutical API workshops, and other sections including the quality management department, warehouse, engineering department, etc., all of which are built according to GMP requirements. Jiuyuan is equipped with advanced production and analysis instruments like chromatography systems, HPLC, and capillary electrophoresis. We offer high-quality products and comprehensive sales services, please contact us.

Company Honor

National New High-tech Enterprise

Key New High-tech Enterprise of National Torch Plan

National superior enterprise of intellectual property

Provincial New High-tech Research & Development Center

Zhejiang Provincial Enterprise Technology Center

Zhejiang Famous Trademark

Zhejiang Jiuyuan Gene Engineering Biopharmaceutical Research Institute

Zhejiang province per mu benefit leading enterprises

Gene-engineering New Drug R&D Technology and Service Sub-platform

Provincial Post-doctoral Scientific Research Working Center

Excellent industrial products in Zhejiang Province

Hangzhou Academician Expert Working Center

Hangzhou Top Ten New High-tech Enterprise

Zhejiang Green Enterprise

Why choose us?

• Our team of professionals is always available to answer any questions and provide any assistance our customers may need.
• Trustworthiness is the primary ethical standard of an enterprise. This requires every employee of the enterprise to take the promise and trustworthiness as the language of communication with customers and the market, and take practical actions to realize their commitments and win the trust of users!
• We are dedicated to providing our customers with the highest quality products and services at competitive prices.
• Our product quality performance indicators are stable and reliable, and have passed the national RhIL-11 (Oprelvekin)– A Drug To Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11 product testing certification.
• At our factory, we take quality and safety seriously, ensuring that our products meet and exceed industry standards.
• With the spirit of pioneering and innovative, unity and forge ahead, we sincerely hope to establish friendly cooperative relations with more business friends.
• We offer a wide range of Oncology API products and can customize solutions to meet specific customer requirements.
• By continuously improving the quality of our products and services, we have gained the recognition of our well-known customers in their respective industries, achieved a stable partnership, and received numerous customer commendations.
• We are committed to delivering reliable and consistent quality products that meet the needs of our customers.
• Together with our all over the world have branches and partners to develop new business areas, maximum common values.

Hot Tags: rhil-11 (oprelvekin)– a drug to increase platelet count, cas no.: 145941-26-0, recombinant human interleukin-11, China rhil-11 (oprelvekin)– a drug to increase platelet count, cas no.: 145941-26-0, recombinant human interleukin-11 manufacturers, suppliers, factory, PegFilgrastim, CAS 135729 62 3, rhG-CSF, Oncology API, Recombinant Human Interleukin-11, Fosaprepitant dimeglumine powder